Background: Traditionally Gustilo III B fractures are treated with external fixators initially, which leads to various complications. Purpose of this study was to evaluate the role of definitive management of Gustilo type III B tibia fractures with intramedullary nailing and flap coverage within two weeks on overall outcome. Materials and methods: This was a single group clinical trial and was conducted in the Department of Orthopedic Surgery and of Burn and Plastic Surgery of CMCH for a period of two years. Twenty two patients were enrolled through inclusion and exclusion criteria. Patients were followed up for 15 months and overall outcomes were measured by Tucker criteria. Results: In this study, Out of 22 patients, male (90.9%) were more than female (9.1%). According to post-operative complications, superficial infection was in 09 (40.9%) patients, deep infection was in 05 (22.7%) patients, 07 (35%) patients had delayed-union, 05 (25%) patients had non union and only 01 (05%) patient had knee stiffness. Mean ± SD time for fracture union was 11.27 ± 2.738 months (Range: 8-15 months). Functional outcome at the final follow-up, 10 (50%) had excellent outcome. Good outcome was in 02 (10%), fair outcome was in 03 (15%) and poor outcome was in 05 (25%) patients respectively according to Tucker et al. criteria, Post-operative infection and non union showed statistical significance according to p value. Conclusion: After 15 months of surgery, intramedullary nailing and flap coverage within two weeks is a feasible treatment option for Gustilo type III B tibia fractures providing excellent to good outcome, minimum fracture union time and low rate of complications. IAHS Medical Journal Vol 4(2), December 2021; 24-27
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.